Organogenesis Holding (ORGO)
2.48
0.00 (0.00%)
Upcoming Events
Latest Headlines
Truist Securities Starts Oranogenesis Holdings (ORGO) at Hold
May 28, 2026 6:06 AM - StreetInsider
BTIG Downgrades Oranogenesis Holdings (ORGO) to Neutral
May 8, 2026 5:33 AM - StreetInsider
Organogenesis Holding (ORGO) Misses Q1 EPS by 15c
May 7, 2026 5:46 PM - StreetInsider
Form 10-Q Organogenesis Holdings For: Mar 31
May 7, 2026 4:20 PM - SEC Filing
Form 8-K Organogenesis Holdings For: May 07
May 7, 2026 4:14 PM - SEC Filing
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 7, 2026 4:05 PM - StreetInsider
Form ARS Organogenesis Holdings For: Dec 31
April 30, 2026 4:26 PM - SEC Filing
Form DEF 14A Organogenesis Holdings For: Jun 15
April 30, 2026 4:22 PM - SEC Filing
Organogenesis completes FDA submission for knee arthritis treatment
April 28, 2026 4:30 PM - StreetInsider
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
April 28, 2026 4:30 PM - StreetInsider
Form 4 Organogenesis Holdings For: Jan 10 Filed by: Grow Brian
April 24, 2026 9:30 PM - SEC Filing
Organogenesis achieves primary endpoint in diabetic foot ulcer trial
April 7, 2026 3:59 AM - StreetInsider
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
April 6, 2026 7:03 PM - StreetInsider
Organogenesis gets FDA approval to file BLA for knee osteoarthritis treatment
April 6, 2026 5:30 PM - StreetInsider
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
April 6, 2026 5:30 PM - StreetInsider
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
April 6, 2026 7:30 AM - Globe NewsWire
Form 4 Organogenesis Holdings For: Mar 09 Filed by: Leibowitz Arthur S
March 11, 2026 9:46 PM - SEC Filing
Form 4 Organogenesis Holdings For: Mar 09 Filed by: Driscoll Michael Joseph
March 11, 2026 5:46 PM - SEC Filing
Full Article List
